ドラッグデリバリーの北米市場:企業概要・規模・シェア・成長・動向・予測(~2024年)

【英語タイトル】North America Drug Delivery Market Analysis : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Data Bridge Market Researchが出版した調査資料(DBMR810107)・商品コード:DBMR810107
・発行会社(調査会社):Data Bridge Market Research
・発行日:2017年10月
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:北米
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥345,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、ドラッグデリバリーの北米市場について調査・分析し、ドラッグデリバリーの北米市場動向、市場予測、セグメント別分析、ドラッグデリバリー市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

In this region, North America Drug Delivery Market is projected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.Based on geography, the North America drug delivery market is segmented into 3 geographical regions, such as,

U.S.,
Mexico,
Canada,

North America drug delivery market competition by top players including –
Johnson & Johnson Services, Inc., is going to dominate the North America drug delivery market followed by Novartis AG along with others such as
F. Hoffmann-La Roche AG,
Pfizer, Inc.,
GlaxoSmithKline plc. ,
Merck & Co., Sanofi,
Antares Pharma,
3M,
Becton Dickinson and Company,
Nemera, Cima Labs, Inc.,
Dali Medical Devices,
Alkermes, Foamis,
Ypsomed,
Skyepharma AG,
Valeant Pharmaceuticals
DSM Biomedical

Catalent, Inc.
The drug delivery market is segmented on the basis of route of administration, end users, and region.
On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.

Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills.
The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. The Injectable drug delivery segment is further segmented into devices and formulations.
The devices segment is categorized as conventional injections, self-injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices.
The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
The injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable.

The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers.
The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
Ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays.

Nasal drug delivery is segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal.
The transdermal topical drug delivery includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices.

The transmucosal drug delivery segment is sub segmented into oral transmucosal and others.
The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of distribution channel the North America drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.

On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.

【レポートの目次】

Table Of Contents

1. Introduction 21
1.1. Overview Of North America Drug Delivery Devices Market 21
1.2. Currency And Pricing 22
1.3. Limitation 22
1.4. Markets Covered 22
2. Market Segmentation 24
2.1. Markets Covered 24
2.2. Geographic Scope 25
2.3. Years Considered For The Study 26
2.4. Currency And Pricing 26
2.5. Research Methodology 27
2.6. Primary Interviews With Key Opinion Leaders 31
2.7. Secondary Sources 32
2.8. Assumptions 32
3. Market Overview 33
3.1. Drivers 34
3.1.1. Rising Prevalence Of Chronic Disease Such As Diabetes 34
3.1.2. Growth In The Development Of Biologics 35
3.1.3. Technological Development 36
3.2. Restraints 37
3.2.1. Risk Of Needle-Stick Injuries And Side Effects 37
3.3. Opportunities 38
3.3.1. Rising Acceptance Of Self Administering Drugs 38
3.3.2. Rising Demand For Biosimilars And Generic Drugs 39
3.3.3. Trend Of Merger And Acquisitions, And Collaborations 40
3.3.4. Focus On Patient Needs 41
3.3.5. Developing And New Emerging Revenue Pockets 42
3.4. Threats 43
3.4.1. Product Recalls 43
3.4.2. Stringent Regulatory And High Pricing 44
3.4.3. Patent Expiry And Patent Cliff 45
4. Executive Summary 46
5. Premium Insights 49
6. North America Drug Delivery Devices Market, By Product Type 52
6.1. Overview 53
6.2. North America Oral Drug Delivery Market, By Product Type 55
6.3. North America Solid Oral Drug Delivery Market,
By Product Type 58
6.4. North America Liquid Oral Drug Delivery Market,
By Product Type 60
6.5. North America Semi-Solid Oral Drug Delivery Market,
By Product Type 62
6.6. North America Pulmonary Drug Delivery Market,
By Product Type 64
6.7. North America Nebulizers Market, By Product Type 67
6.8. North America Injectable Drug Delivery Market,
By Product Type 69
6.9. North America Injectable Drug Delivery Devices,
By Product Type 71
6.9.1. North America Conventional Injectable Drug Delivery Devices Market 72
6.9.2. North America Self-Injection Drug Delivery Devices Market, By Product Type 76
6.10. North America Injectable Drug Delivery Formulations Market, By Product Type 80
6.11. North America Ophthalmic Drug Delivery Market,
By Product Type 83
6.12. North America Ophthalmic Drug Delivery Formulations Market,By Form 85
6.13. Ophthalmic Drug Delivery Devices, By Product Type 88
6.14. North America Nasal Drug Delivery Market, By Product Type 90
6.15. North America Topical Drug Delivery Market, By Product Type 92
6.16. North America Transdermal Drug Delivery Devices Market, By Product Type 94
6.17. North America Topical Drug Delivery Formulations Market, By Product Type 96
6.17.1. North America Semi Solid Topical Drug Delivery Formulations Market, By Type 97
6.17.2. North America Liquid Topical Drug Delivery Formulations Market, By Type 99
6.17.3. North America Solid Topical Drug Delivery Formulations Market, By Type 100
6.18. North America Implantable Drug Delivery Market,
By Product Type 102
6.19. North America Transmucosal Drug Delivery Market,
By Product Type 104
6.20. North America Oral Transmucosal Drug Delivery Market, By Product Type 106
6.21. North America Oral Transmucosal Drug Delivery Market, By Product Type 108
7. North America Drug Delivery Devices Market, By End User 110
7.1. Overview 111
8. North America Drug Delivery Devices Market, By Distribution Channel 114
8.1. Overview 115

9. Drug Delivery Market, By Geography 117
9.1. North America Drug Delivery Devices Market 118
9.2. U.S. Drug Delivery Devices Market 140
9.3. Canada Drug Delivery Devices Market 159
9.4. Mexico Drug Delivery Devices Market 178
10. North America Drug Delivery Devices Market, Company Share 197
10.1. Company Share Analysis: North America 197
11. Company Profiles 199
11.1. Bayer Ag 199
11.1.1. Company Overview 199
11.1.2. Revenue Analysis 200
11.1.3. Product Portfolio 200
11.1.4. Recent Developments 201
11.2. F. Hoffmann-La Roche Ltd 204
11.2.1. Company Overview 204
11.2.2. Revenue Analysis 204
11.2.3. Product Portfolio 205
11.2.4. Recent Developments 210
11.3. Glaxosmithkline Plc 212
11.3.1. Company Overview 212
11.3.2. Revenue Analysis 212
11.3.3. Product Portfolio 213
11.3.4. Recent Developments 213
11.4. Johnson & Johnson Services, Inc. 215
11.4.1. Company Overview 215
11.4.2. Revenue Analysis 216
11.4.3. Product Portfolio 217
11.4.4. Recent Developments 218
11.5. Novartis 221
11.5.1. Company Overview 221
11.5.2. Revenue Analysis 221
11.5.3. Product Portofolio 222
11.5.4. Recent Developments 222
11.6. Pfizer, Inc. 227
11.6.1. Company Overview 227
11.6.2. Revenue Analysis 227
11.6.3. Product Portfolio 228
11.6.4. Recent Developments 234
11.7. 3M 238
11.7.1. Company Overview 238
11.7.2. Revenue Analysis 238
11.7.3. Product Portfolio 239
11.7.4. Recent Developments 239
11.8. Antares Pharma, Inc. 240
11.8.1. Company Overview 240
11.8.2. Revenue Analysis 240
11.8.3. Product Portfolio 241
11.8.4. Recent Developments 241
11.9. Merck & Co. 243
11.9.1. Company Overview 243
11.9.2. Revenue Analysis 244
11.9.3. Product Portfolio 244
11.9.4. Recent Developments 246

11.10. Sanofi 249
11.10.1. Company Overview 249
11.10.2. Revenue Analysis 250
11.10.3. Product Portofolio 250
11.10.4. Recent Developments 251
12. Related Reports 254

Figures List

Figure 1 North America Drug Delivery Devices Market: Segmentation 24
Figure 2 North America Drug Delivery Devices Market: Geograhic Scope 25
Figure 3 North America Drug Delivery Devices Market: Data Triangulation 27
Figure 4 North America Drug Delivery Devices Market: Research Snapshot 28
Figure 5 North America Drug Delivery Devices Market: Bottom Up Approach 30
Figure 6 North America Drug Delivery Devices Market: Top Down Approach 30
Figure 7 North America Drug Delivery Devices Market: Interviews By Country And Designation 31
Figure 8 North America Dominates The Market For Drug Delivery Devices In 2016 And Is Expected To Continue This Trend In The Forecast Period To 2024 48
Figure 9 Technological Development In Self Administered And Non-Invasive Drug Delivery Technologies Is Expected To Drive The Market For North America Drug Delivery Devices In The Forecast Period 2017 To 2024 49
Figure 10 Oral Drug Delivery Market Segment Is Expected To Account For The Largest Share Of The North America Drug Delivery Devices Market In 2024 50
Figure 11 United States Is The Highest Growing And Most Profitable Revenue Pockets For North America Drug Delivery Devices Manufacturers In The Forecast Period 2017 To 2024 51
Figure 12 North America Drug Delivery Market: By Product Type, Snapshot 2024 54
Figure 13 North America Drug Delivery Market: By End-User, Snapshot 2016 111
Figure 14 North America Drug Delivery Devices Market: By Distribution Channel, Snapshot 2016 115
Figure 15 North America Drug Delivery Devices Market: By Country, Snapshot 2017& 2024 119
Figure 16 Injectable Drug Delivery Is Expected To Be Growing At The Highest Cagr In The Forecast Period In North America Drug Delivery Devices Market 121
Figure 17 Injectable Drug Delivery Is Expected To Be Growing At The Highest Cagr In The Forecast Period In U.S. Drug Delivery Devices Market 141
Figure 18 Injectable Drug Delivery Is Expected To Grow At The Highest Cagr In The Forecast Period In Canada Drug Delivery Devices Market 160
Figure 19 Injectable Drug Delivery Is Expected To Grow At The Highest Cagr In The Forecast Period In Mexico Drug Delivery Devices Market 178
Figure 20 North America Drug Delivery Market: Company Share 2016 (%) 197

【レポートのキーワード】

ドラッグデリバリー

★調査レポート[ドラッグデリバリーの北米市場:企業概要・規模・シェア・成長・動向・予測(~2024年)] (コード:DBMR810107)販売に関する免責事項を必ずご確認ください。
★調査レポート[ドラッグデリバリーの北米市場:企業概要・規模・シェア・成長・動向・予測(~2024年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆